Clinical trial
The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests…
NCT00359138 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00359138 |
|---|---|
| Title | The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441) |
| Official title | A Double-blind, Double-dummy, Parallel-group, Placebo-controlled, Randomized Study to Assess the Duration of the Suppressive Effects of Desloratadine on the Cutaneous Allergen-induced Wheal and Flare (1) Response After Discontinuation |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypersensitivity |
| Intervention type | Drug |
| Interventions | desloratadine, levocetirizine, Desloratadine placebo tablet, Levocetirizine placebo capsule |
| Enrollment | 36 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Aug 1, 2006 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: